Research Archive — Page 36 of 131
-
August 8, 2023
Chronic complications from immunotherapies more prevalent and persistent than previously shown among melanoma survivors
A Vanderbilt study has found that chronic immunotherapy-related complications are more prevalent and persistent than previously shown among melanoma survivors. -
August 3, 2023
Study finds hallmarks of T cell exhaustion within hours of tumor exposure
Vanderbilt researchers found that T cells become “exhausted” within hours of encountering a tumor, challenging existing ideas about how T cells become dysfunctional. -
August 2, 2023
Personalizing treatment for sinus syndrome
Understanding the inflammatory characteristics of subtypes of chronic rhinosinusitis with polyps should assist with selection of effective therapies, Vanderbilt researchers report. -
August 2, 2023
VUMC receives $28 million to lead national study of COVID-diabetes link
Researchers at Vanderbilt University Medical Center have received a four-year, $28 million grant from the National Institute of Diabetes and Digestive and Kidney Diseases to study the relationship between COVID-19 and diabetes. -
July 26, 2023
Nancy Cox receives American Society of Human Genetics Leadership Award
Nancy Cox, PhD, director of the Vanderbilt Genetics Institute, is the recipient of the 2023 ASHG Leadership Award from the American Society of Human Genetics. -
July 25, 2023
Signaling pathways in liposarcomas
A broad bioinformatics approach revealed that Hedgehog signaling is upregulated in dedifferentiated liposarcoma, suggesting this pathway may be an early indicator of poor prognosis and a potential therapeutic target. -
July 24, 2023
Study explores how often children diagnosed with flu experience serious neuropsychiatric side effects
A Vanderbilt study is among the first to quantify how often children diagnosed with flu experience serious neuropsychiatric side effects.